SCHEMBL6165592

SCHEMBL6165592

CC(=O)S[C@@H]1CC(=O)N(Cc2ccc(Oc3ccc(F)cc3)cc2)C1

nearest known ligand 0.53

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
HTT P42858 1/20 0.53
MMP2 P08253 2/20 0.50
MMP13 P45452 2/20 0.50
MMP1 P03956 1/20 0.50
MMP3 P08254 1/20 0.50
MMP9 P14780 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.42
CYP3A4 P08684 1/20 0.40
CYP2C19 P33261 1/20 0.40
ALDH1A1 P00352 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
KMT2A Q03164 2/20 0.40
TP53 P04637 1/20 0.39
S1PR5 Q9H228 1/20 0.39
LMNA P02545 1/20 0.39
PKM P14618 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6159098 1.00 HTT (0.53) HTTMMP2MMP13MMP1MMP3
SCHEMBL6159377 1.00 HTT (0.53) HTTMMP2MMP13MMP1MMP3
SCHEMBL6158416 0.90 SMN1; SMN2 (0.45) HTTSMN1; SMN2CYP3A4CYP2C19ALDH1A1
SCHEMBL6160144 0.90 SMN1; SMN2 (0.45) HTTSMN1; SMN2CYP3A4CYP2C19ALDH1A1
SCHEMBL6162824 0.90 ALDH1A1 (0.43) HTTMMP2MMP13MMP1MMP3
SCHEMBL6159136 0.90 SMN1; SMN2 (0.43) HTTMMP2MMP13MMP1MMP3
SCHEMBL6158718 0.90 KMT2A (0.49) HTTMMP2MMP13MMP1MMP3
SCHEMBL6158676 0.90 KMT2A (0.49) HTTMMP2MMP13MMP1MMP3
SCHEMBL6158423 0.90 SMN1; SMN2 (0.45) HTTSMN1; SMN2CYP3A4CYP2C19ALDH1A1
SCHEMBL6160166 0.90 ALDH1A1 (0.50) MMP13MMP1SMN1; SMN2CYP3A4CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6953789-B2 Thiol compounds, their production and use TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2005-10-11 US disclosed
US-20040157894-A1 Thiol compounds, their production and use TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2004-08-12 US disclosed
US-6699881-B2 MATRIX METALLOPROTEASE INHIBITORS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2004-03-02 US disclosed
US-20030078253-A1 Thiol compounds, their production and use TAKEDA PHARMACEUTICAL COMPANY, LIMITED (JP) 2003-04-24 US disclosed
US-6420415-B1 Thiol compounds, their production and use TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2002-07-16 US disclosed
EP-1132379-A1 NOVEL THIOL DERIVATIVES, PROCESS FOR PRODUCING THE SAME AND UTILIZATION THEREOF Takeda Chemical Industries, Ltd. (JP) 2001-09-12 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030078253-A1 Thiol compounds, their production and use TST, QSOX1, SULT1E1 HTT 1420/4885MMP2 4550/4885MMP13 4264/4885
US-20040157894-A1 Thiol compounds, their production and use TST, SULT1E1, QSOX1 HTT 1459/4885MMP2 4468/4885MMP13 4138/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.